The Supreme Court of the United States has declined to hear an appeal by agricultural and pharmaceutical giant Bayer AG, a decision that threatens to disrupt the American agricultural sector and undermine the authority of federal regulatory bodies. By refusing to review a lower court ruling, the Supreme Court has allowed state-level product liability lawsuits to proceed against the manufacturer of Roundup weedkiller. This decision leaves businesses exposed to a patchwork of inconsistent state regulations and trial-lawyer-driven litigation, despite federal regulators repeatedly affirming the product's safety.

The central legal issue in the case was whether federal law preempts state-law claims. Under the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA), the U.S. Environmental Protection Agency (EPA) possesses the statutory authority to evaluate and approve pesticide labels. The EPA has consistently reviewed the scientific literature surrounding glyphosate, the active ingredient in Roundup, and has repeatedly concluded that the chemical does not pose a carcinogenic risk when used as directed. Bayer argued that because the EPA prohibits false or misleading labels—and has explicitly stated that a cancer warning on glyphosate would be scientifically unwarranted—state-level courts should not be permitted to penalize companies for failing to include such warnings.

The Supreme Court’s refusal to intervene leaves intact a $25 million judgment awarded to California resident Edwin Hardeman, who claimed his non-Hodgkin's lymphoma was caused by Roundup. Legal experts warn that this decision will embolden plaintiffs' attorneys to pursue thousands of remaining lawsuits, creating a massive financial burden on a vital sector of the economy. The rise of mass tort litigation has increasingly targeted major employers, threatening American competitiveness and diverting billions of dollars from research and development into legal settlements.

Bayer’s 2018 acquisition of Monsanto for $63 billion has turned into an ongoing financial crisis due to the volume of litigation. While Bayer has attempted to manage its liabilities through a structured settlement program, the threat of continuous lawsuits remains a heavy burden on its operations. This legal vulnerability has broader economic implications, as uncertainty surrounding essential agricultural inputs can disrupt supply chains and elevate costs for American farmers who rely on affordable crop protection tools.

American agricultural groups have expressed deep concern over the long-term consequences of the litigation. Glyphosate is a critical component of modern conservation tillage practices, which reduce soil erosion and lower carbon emissions by minimizing the need for plowing. If litigation forces manufacturers to pull effective weedkillers from the market or drastically increase prices to cover legal liabilities, farmers may be forced to return to more labor-intensive and environmentally taxing cultivation methods. This shift could ultimately lead to higher food prices for consumers at a time of persistent inflation.